Michael Mendoza serves as Senior Vice President, Biometrics and Data Science at Koneksa, where he leads the company’s biometrics and data-driven drug development strategy, advancing scalable, technology-enabled clinical research. With more than 28 years of experience driving innovation in clinical data management, digital trial technologies, and data science across pharmaceutical, biotech, and CRO organizations, Michael brings a depth of expertise that directly enhances the value Koneksa delivers to its partners.

​

Throughout his career, Michael has applied extensive hands-on knowledge of EDC, CTMS, RTSM, eCOA, clinical data lakes, centralized monitoring, and AI-enabled analytics to streamline the full clinical data lifecycle, from study startup through regulatory submission. His leadership ensures that every Koneksa engagement benefits from robust data integration, real-time insights, and inspection-ready deliverables that accelerate drug development and strengthen decision-making.

​

A proven innovator and mentor, Michael has built and inspired global, high-performing teams that consistently deliver excellence across complex programs. He is recognized for his ability to align emerging technologies with the evolving needs of clinical research, enabling Koneksa’s clients to run smarter, faster, and more data-rich trials. Through his vision and expertise, Koneksa transforms clinical data into actionable insights driving higher data quality, reduced development timelines, and improved outcomes for patients worldwide.